日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An integrative analysis reveals the mechanism of plastic stabilizers inducing breast cancer

综合分析揭示了塑料稳定剂诱发乳腺癌的机制

Huo, Xingfa; Duan, Xueqin; Huang, Xiaojuan; Xue, Linyuan; Zhao, Lantao; Li, Yufeng; Zhang, Xiaochun; Zhou, Na

Combination therapy with Chicoric acid and PD-1/PD-L1 blockade improves the immunotherapy response in patient-derived ovarian cancer xenograft model.

菊苣酸与 PD-1/PD-L1 阻断剂联合治疗可改善患者来源卵巢癌异种移植模型的免疫治疗反应

Lan Hongwei, Zhu Jingjuan, Hou Helei, Zhang Chuantao, Huo Xingfa, Zhang Yuming, Yang Fangfang, Zhou Na, Zhang Xiaochun

ARID1A deficiency attenuates the response to EGFR-TKI treatment in lung adenocarcinoma

ARID1A缺陷会减弱肺腺癌对EGFR-TKI治疗的反应

Yang, Fangfang; Hou, Helei; Wang, Guanqun; Fu, Guangming; Huo, Xingfa; Duan, Xueqin; Zhou, Na; Zhang, Xiaochun

Nomogram for predicting the risk and prognosis of lung metastasis of four subtypes of breast cancer: A population-based study from SEER

基于SEER数据库的人群研究:预测四种乳腺癌亚型肺转移风险和预后的列线图

Xin, Yuanfang; Zhang, Guoxin; Dong, Qiuxia; Liu, Yaobang; Huo, Xingfa; Guan, Yumei; Zheng, Yonghui; Fang, Qianqian; Ren, Dengfeng; Zhao, Fuxing; Li, Zitao; Liu, Xinlan; Zhao, Jiuda

Comparative effectiveness and safety of treatment regimens for recurrent advanced ovarian cancer: a systematic review and network meta-analysis

复发性晚期卵巢癌治疗方案的比较疗效和安全性:系统评价和网络荟萃分析

Huo, Xingfa; Tian, Tian; Zhang, Xiaochun; Zhou, Na

Integrative analysis of fatty acid metabolism and identification of ANLN as a novel prognostic marker in lung adenocarcinoma

脂肪酸代谢的整合分析及ANLN作为肺腺癌新型预后标志物的鉴定

Yang, Fangfang; Jiang, Peng; Huo, Xingfa; Xu, Xiao; Zhou, Na; Zhang, Xiaochun

Mendelian randomization and transcriptomic data analysis reveals the causal association between gout and breast cancer

孟德尔随机化和转录组数据分析揭示了痛风与乳腺癌之间的因果关系

Zhang, Hengheng; Huo, Xingfa; Li, Jinming; Li, Na; Xiao, Wenjun; Wang, Miaozhou; Zhao, Fuxing; Zhao, Yi

Conversion therapy with chemoimmunotherapy induced pCR in a stage IV lung squamous cell carcinoma patient harboring EGFR exon 20 insertion

接受化疗免疫疗法转化治疗的 EGFR 20 号外显子插入突变 IV 期肺鳞状细胞癌患者达到病理完全缓解 (pCR)。

Xu, Mingjin; Huo, Xingfa; Zhang, Chuantao; Zhang, Xuchen; Wang, Huiyun; Yang, Hongmin; Ge, Nan; Wang, Yongjie; Hou, Helei

Treatment options for patients with human epidermal growth factor 2-positive breast cancer brain metastases: A systematic review and meta-analysis

人表皮生长因子2阳性乳腺癌脑转移患者的治疗选择:系统评价和荟萃分析

Huo, Xingfa; Shen, Guoshuang; Wang, Tianzhuo; Li, Jinming; Xie, Qiqi; Liu, Zhen; Wang, Miaozhou; Zhao, Fuxing; Ren, Dengfeng; Zhao, Jiuda

Multi-omics analysis of expression profile and prognostic values of connexin family in LUAD

肺腺癌中连接蛋白家族表达谱的多组学分析及其预后价值

Jiang, Peng; Huo, Xingfa; Dong, Bowen; Zhou, Na; Zhang, Xiaochun